Oryzon Genomics S.A. (ORN)
XSTU
2.73
+0.0060 (+0.22%)
Real-time Data
06:00 AM
Day's Range
2.722.75
52 wk Range
2.633.85
Financial Statements - ORN - Oryzon Genomics S.A.
Revenue
0
Net Income
-2.60M▲ 31.7%
EBITDA
-4.80M▼ 8.8%
Free Cash Flow
-13.39M▲ 3.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | -10.65M | -7.34M | -13.94M | -15.23M | -9.86M | -8.99M |
| Gross Profit | 10.65M | 7.34M | 13.94M | 15.23M | 9.86M | 8.99M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -5.70M | -4.60M | -4.54M | -5.48M | -7M | -4.28M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -5.59M | -5.79M | -6.10M | -6.55M | -7.17M | -4.77M |
| Income Tax | -2.99M | -1.98M | -2.75M | -2.32M | -2.49M | -1.37M |
| Net Income | -2.60M | -3.81M | -3.35M | -4.23M | -4.68M | -3.39M |
| EPS Basic | -0.039483 | -0.058908 | -0.055075 | -0.075504 | -0.088833 | -0.064432 |
| EPS Diluted | -0.039483 | -0.058908 | -0.055075 | -0.075504 | -0.088833 | -0.064432 |
| Basic Shares Outstanding | 77.51M | 64.74M | 60.87M | 56.04M | 52.76M | 52.76M |
| Diluted Shares Outstanding | 77.51M | 64.74M | 60.87M | 56.04M | 52.76M | 52.76M |
| Ebit | -4.99M | -4.52M | -4.21M | -5.43M | -6.72M | -4.30M |
| Ebitda | -4.80M | -4.42M | -4.26M | -5.07M | -6.57M | -4.16M |
| Net Income Continuous Operations | -5.59M | -5.79M | -6.10M | -6.55M | -7.17M | -4.77M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
